Investing Profile

Elena Viboch

InvestorVC
Partner at General Catalyst
generalcatalyst.comSan Francisco Bay Area
Photo of Elena Viboch, Partner at General Catalyst
Picture
Picture

2 Investors

Connected to Saar Gur (CRV), Lisa Marrone (August Capital).

cb
$500K - $2.0M
$500K
10
$1.1B
CompanyStageDateRound SizeTotal Raised
Medeloop
Series ANov 2024$16M
SeedSep 2023$8M
$24M
Co-investors: Sara Thomas Deshpande (Maven Ventures), Magaly Charbonneau (iNovia Capital)
CTRL Therapeutics
SeedApr 2023$10M
$10M
Faro Health
Series AFeb 2023$20M
$35M
Co-investors: Andy Harrison (Section 32)
Paradigm
Series AJan 2023$200M
$240M
Co-investors: Hemant Taneja (General Catalyst), Ramnik Arora (FTX Ventures), Bilal Zuberi (Lux Capital), Stephen Knight (F-Prime Capital Partners), Brett Cook (F-Prime Capital Partners), Robert Nelsen (ARCH Venture Partners), Jay Markowitz (ARCH Venture Partners), Alaa Halawa (Mubadala), Jared Friedman (Y Combinator), Scott Belsky, Eoghan McCabe, Arash Ferdowsi
ArriVent Biopharma
Series BDec 2022$160M
$160M
Co-investors: Carl Gordon (OrbiMed), James Healy (Sofinnova Investments)
Vial
Series BNov 2022$67M
$100M
Co-investors: Josh Buckley (Buckley Ventures), Adam Rothenberg (BoxGroup), Nimi Katragadda (BoxGroup), Greg Rosen (BoxGroup), Hemant Taneja (General Catalyst), Jeffrey Silverstein (Andreessen Horowitz), David Tisch (BoxGroup), TJ Nahigian (Base10 (Base10 Partners) ), Blake Byers (Byers Capital), Gordon Wintrob, Zak Kukoff, Nikhil Krishnan
Odyssey Therapeutics
Series BOct 2022$170M
$490M
Co-investors: Carl Gordon (OrbiMed), Jill carroll (SR One), Lorence Kim (Third Rock Ventures)
Deep Genomics
Series CJul 2021$180M
$240M
Co-investors: Vinod Khosla (Khosla Ventures), Adam D'Augelli (True Ventures), Deep Nishar (General Catalyst), Steve Jurvetson (Future Ventures), Shivon Zilis